Class II · Moderate risk
Edetate Disodium150mg/mL PFV
Lack of Assurance of Sterility
FDA Drug Recalls
5,405 recalls, newest first
Class II · Moderate risk
Edetate Disodium 15% Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Edetate Disodium 15% Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Edetate Disodium 30% Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Edetate Calcium Disodium 150mg/Ml Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Dimercapto-Propanesulfonic 5%
Lack of Assurance of Sterility
Class II · Moderate risk
diazePAM 5 MG/ML INJECTION SOLUTION
Lack of Assurance of Sterility
Class II · Moderate risk
Dextrose 50% Injection Solution
Lack of Assurance of Sterility
Class II · Moderate risk
Dextrose 50% Injection Solution
Lack of Assurance of Sterility
Class II · Moderate risk
Dexpanthenol 250mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
Cyancobalamin 1200mcg/Ml Mdv Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Copper 0.4MG/ML
Lack of Assurance of Sterility
Class II · Moderate risk
Calcium Gluconate 5% Injection Solution
Lack of Assurance of Sterility
Class II · Moderate risk
Calcium Chloride 100mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
Buffered Lidocaine HCL 1% Injection Sol
Lack of Assurance of Sterility
Class II · Moderate risk
Buffered Lidocaine HCL 1% Injection Solution
Lack of Assurance of Sterility
Class II · Moderate risk
Buffered Lidocaine 1%+epi 1:100
Lack of Assurance of Sterility
Class II · Moderate risk
Avastin
Lack of Assurance of Sterility
Class II · Moderate risk
SUCCINYLcholine Chloride
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk
SUCCINYLcholine Chloride
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk
Sodium Bicarbonate INJ 8.4%
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk
Riboflavin 5-Phosphate Sodium Ophthalmic Solution
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk
Phenylephrine HCL PF INJ in 0.9% Sodium Chloride
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk
Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk
Neostigmine Methylsulfate
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.